Literature DB >> 1353369

The relationship of structural brain imaging parameters to antipsychotic treatment response: a review.

L Friedman1, C Lys, S C Schulz.   

Abstract

Over the last decade, a number of studies have attempted to relate brain morphology to treatment response to neuroleptics. This approach has scientific potential to define subtypes of schizophrenia as well as potential clinical utility. In the present report, a review of 33 studies, including a meta-analysis, is provided. Although the overall test of the effect was not significant, the analysis revealed marked heterogeneity in the results of the various studies. The following factors were significant predictors of effect size: age, illness duration and age of onset of the patient cohort, the percentage of patients with marked structural abnormality included in the study overall, the duration of treatment and the degree of symptom improvement in the study overall. The following factors were unrelated to study effect size: date of study, gender, and the presence of a washout period. In future studies, attention to the parameters utilized in the meta-analysis should help to clarify the strength and generality of the relationship between brain morphology and treatment response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353369      PMCID: PMC1188400     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  43 in total

1.  Amphetamine challenge test, response to treatment, and lateral ventricle size in schizophrenia.

Authors:  A K Pandurangi; S C Goldberg; D D Brink; M H Hill; A N Gulati; R M Hamer
Journal:  Biol Psychiatry       Date:  1989-01-15       Impact factor: 13.382

2.  Response to drugs in schizophrenia: the influence of family history, obstetric complications and ventricular enlargement.

Authors:  V L Nimgaonkar; S Wessely; L E Tune; R M Murray
Journal:  Psychol Med       Date:  1988-08       Impact factor: 7.723

Review 3.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

4.  Correlates of lateral ventricular size in chronic schizophrenia, I: Behavioral and treatment response measures.

Authors:  M F Losonczy; I S Song; R C Mohs; N A Small; M Davidson; C A Johns; K L Davis
Journal:  Am J Psychiatry       Date:  1986-08       Impact factor: 18.112

5.  Cortical atrophy and white matter density in the brains of schizophrenics and clinical response to neuroleptics.

Authors:  R C Smith; R Baumgartner; G K Ravichandran; J Largen; M Calderon; A Burd; M Mauldin
Journal:  Acta Psychiatr Scand       Date:  1987-01       Impact factor: 6.392

6.  Lateral ventricular enlargement and clinical response in schizophrenia.

Authors:  R C Smith; R Baumgartner; G K Ravichandran; M Mauldin; A Burd; G Vroulis; J Gordon; M Calderon
Journal:  Psychiatry Res       Date:  1985-03       Impact factor: 3.222

7.  Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results.

Authors:  O M Wolkowitz; A Breier; A Doran; J Kelsoe; P Lucas; S M Paul; D Pickar
Journal:  Arch Gen Psychiatry       Date:  1988-07

8.  Cortical atrophy in schizophrenia. Prevalence and associated features.

Authors:  A Vita; E Sacchetti; A Calzeroni; C L Cazzullo
Journal:  Schizophr Res       Date:  1988 Sep-Oct       Impact factor: 4.939

9.  Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.

Authors:  T Kolakowska; A O Williams; M Ardern; M A Reveley; K Jambor; M G Gelder; B M Mandelbrote
Journal:  Br J Psychiatry       Date:  1985-03       Impact factor: 9.319

10.  A comprehensive study of chronic schizophrenic patients. II: Biological, neuropsychological, and clinical correlates of CT abnormality.

Authors:  A K Pandurangi; M J Dewan; M Boucher; B Levy; T Ramachandran; K Bartell; P A Bick; B H Phelps; L Major
Journal:  Acta Psychiatr Scand       Date:  1986-02       Impact factor: 6.392

View more
  5 in total

Review 1.  Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies.

Authors:  Goda Tarcijonas; Deepak K Sarpal
Journal:  Neurobiol Dis       Date:  2018-06-25       Impact factor: 5.996

2.  Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?

Authors:  Stephen M Lawrie; Bayanne Olabi; Jeremy Hall; Andrew M McIntosh
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

Review 3.  Factors associated with response to clozapine in schizophrenia: a review.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Haruo Kashima
Journal:  Psychopharmacol Bull       Date:  2011

Review 4.  Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research.

Authors:  Paola Dazzan; Celso Arango; Wolfgang Fleischacker; Silvana Galderisi; Birte Glenthøj; Stephan Leucht; Andreas Meyer-Lindenberg; Rene Kahn; Dan Rujescu; Iris Sommer; Inge Winter; Philip McGuire
Journal:  Schizophr Bull       Date:  2015-03-23       Impact factor: 7.348

Review 5.  Neuroimaging biomarkers to predict treatment response in schizophrenia: the end of 30 years of solitude?

Authors:  Paola Dazzan
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.